Sapio Sciences Launches New Molecule Solution Platform
Sapio chemistry solution unifies small-molecule and large-molecule discovery workflows on a single platform.
Sapio Sciences announced the launch of its Sapio chemistry solution, which unifies small-molecule and large-molecule discovery workflows on a single platform. According to the company, the technology enables scientists to draw insights across all their organization’s discovery experiments.
“Many organizations are still running decades-old electronic laboratory notebooks (ELNs) and other software for capturing chemical synthesis experiments and registering small molecules,” said Kevin Cramer, president, CEO, Sapio Sciences. “Large-molecule and small-molecule discovery have traditionally been managed on disparate systems, creating artificial islands that impede scientific collaboration and decision-making. Sapio is excited to give biopharma organizations the opportunity to consolidate all their chemistry experiments on a modern, unified lab platform.”
Reference
Sapio Sciences Unifies Small- and Large-Molecule Discovery on a Single Platform. Business Wire. October 9, 2023. Accessed October 10, 2023. https://www.businesswire.com/news/home/20231009525095/en/Sapio-Sciences-Unifies-Small--and-Large-Molecule-Discovery-on-a-Single-Platform
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment
March 14th 2025New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.
